Marijuana use linked to a greater risk of heart damage

Marijuana use is associated with a heightened risk of myocardial injury among individuals with no prior history of cardiovascular disease (CVD), according to new findings published in the American Journal of Cardiology.

“Multiple observational studies have demonstrated an association with cannabis use and acute myocardial infarction, especially among young adults,” wrote lead author Travis M. Skipina, MD, of the department of internal medicine at Wake Forest School of Medicine, and colleagues. “However, little is known about the connection with subclinical or electrocardiographic myocardial injury.”

Skipina et al. explored data from nearly 3,500 adult participants from the Third National Health and Nutrition Examination Survey. Patients with a history of CVD were not included in this analysis. While 26% of participants had a history of marijuana use, 15.5% had myocardial injury, as identified by electrocardiographic findings. The researchers worked to identify any connections between the two that they could find.

Overall, cannabis users had a 43% greater chance of myocardial injury compared to individuals who have never used it. This link was especially apparent when participants also had a history of hypertension.

“This is a novel finding that underscores the harmful effects of cannabis use on CV health and highlights the need for further, controlled studies regarding cannabis and CV disease as the drug becomes more accepted by the general population,” the authors concluded. “Additionally, the finding of effect modification by co-existent hypertension merits a personalized risk assessment when counseling patients on cannabis use.”

The full study can be read here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.